Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting altered tumour metabolism is an emerging therapeutic strategy for cancer treatment. The metabolic reprogramming that accompanies the development of malignancy creates targetable differences between cancer cells and normal cells, which may be exploited for therapy. There is also emerging ev...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jiaqi Li, Jie Qing Eu, Li Ren Kong, Lingzhi Wang, Yaw Chyn Lim, Boon Cher Goh, Andrea L. A. Wong
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2020-10-01
Col·lecció:	Molecules
Matèries:	cancer cell metabolism tumour microenvironment metabolic reprogramming targeted therapy immunotherapy
Accés en línia:	https://www.mdpi.com/1420-3049/25/20/4831

Ítems similars

Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
per: Dongki Yang, et al.
Publicat: (2019-03-01)

Metabolism, metabolites, and macrophages in cancer
per: Mengyuan Li, et al.
Publicat: (2023-07-01)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
per: Yi Lin, et al.
Publicat: (2022-10-01)

Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumour microenvironment
per: Mary B Mockler, et al.
Publicat: (2014-05-01)

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
per: Haixia Zhang, et al.
Publicat: (2024-09-01)

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
per: Hua Cheng, et al.
Publicat: (2024-01-01)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
per: Shi Dong, et al.
Publicat: (2022-12-01)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
per: Yifei Zhu, et al.
Publicat: (2022-08-01)

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
per: Alice Benoit, et al.
Publicat: (2023-07-01)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
per: Lihaoyun Huang, et al.
Publicat: (2024-03-01)

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
per: Yanru Long, et al.
Publicat: (2024-01-01)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
per: Soumik Pal, et al.
Publicat: (2022-12-01)

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer
per: Xu Chang, et al.
Publicat: (2022-05-01)

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
per: Shinjini Bandopadhyay, et al.
Publicat: (2023-08-01)

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
per: Dongming Li, et al.
Publicat: (2024-01-01)

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
per: Zhi-Xun Guo, et al.
Publicat: (2025-01-01)

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
per: Ming Zhang, et al.
Publicat: (2022-09-01)

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
per: Junpeng Zhao, et al.
Publicat: (2024-06-01)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
per: Jesse D. Armitage, et al.
Publicat: (2021-01-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
per: Jing Xue, et al.
Publicat: (2023-12-01)

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
per: Di Chen, et al.
Publicat: (2024-09-01)

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
per: Changqian Wang, et al.
Publicat: (2024-03-01)

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer
per: Yongwen Luo, et al.
Publicat: (2022-10-01)

Advances in reprogramming of energy metabolism in tumor T cells
per: Liu Xuekai, et al.
Publicat: (2024-02-01)

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
per: Andrea Nicolini, et al.
Publicat: (2024-07-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
per: Emily J. Kay, et al.
Publicat: (2023-04-01)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
per: Mengdi Ren, et al.
Publicat: (2022-08-01)

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison
per: Jing Xu, et al.
Publicat: (2024-05-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
per: Hor-Yue Tan, et al.
Publicat: (2018-02-01)

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
per: Xiaoxue Cao, et al.
Publicat: (2023-03-01)

Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation
per: Bijing Xiao, et al.
Publicat: (2024-05-01)

High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming
per: Renchao Zou, et al.
Publicat: (2025-02-01)

Editorial: Tumor microenvironment and metabolic reprogramming in cancer
per: Xiaoling Cui, et al.
Publicat: (2024-10-01)

Metabolic reprogramming in the tumor microenvironment of liver cancer
per: Jian Lin, et al.
Publicat: (2024-01-01)

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling
per: Jianhang Jiao, et al.
Publicat: (2024-10-01)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
per: Qi Xiao, et al.
Publicat: (2023-05-01)

A review of lactate-lactylation in malignancy: its potential in immunotherapy
per: Jinhui Zha, et al.
Publicat: (2024-05-01)

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies
per: Yang Yu, et al.
Publicat: (2024-07-01)

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
per: Xingtao Zhao, et al.
Publicat: (2023-04-01)

Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
per: Haoqiang Yang, et al.
Publicat: (2025-02-01)